Pfizer Inc
NYSE: PFE
$28.46
-$0.40 (-1.4%)
Closing Price on October 29, 2024
PFE Articles
Pfizer is scheduled to report its fourth-quarter financial results before the markets open on Tuesday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of the three Dow Jones Industrial Average companies that are reporting their quarterly results this week.
Published:
Last Updated:
Some of the Dow stocks that are down in 2016 haven't even reported earnings. This is the market bracing for bad news, but one cannot wonder if that means that the earnings bar is being lowered...
Published:
Last Updated:
Needless to say, the stock market can be a very cruel mistress. Companies can report great numbers, but if the guidance is light? Look out!
Published:
Last Updated:
The January 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
Published:
Last Updated:
Perhaps not surprisingly, in early January, short interest was on the rise for most of the top six most heavily shorted stocks traded on the New York Stock Exchange.
Published:
Last Updated:
These stocks are not exciting, but neither are market sell-offs and big paper losses like we have seen in January.
Published:
Last Updated:
Thursday's top analyst calls include Alcoa, GoPro, MetLife, Netflix, SUPERVALU, Walt Disney, Williams Companies and Yelp.
Published:
Last Updated:
A bull market interrupted is how many investors likely feel at the start of 2016. These are the seven Dow stocks that will be needed to drive the Dow higher in 2016.
Published:
Last Updated:
The short interest data have been released for the December 31 settlement date. For most of the selected pharmaceutical stocks short interest was up.
Published:
Last Updated:
General Electric saw its short interest drop sharply between the December 15 and December 31 settlement dates for the second period in a row. Meanwhile, short sellers piled on to Pfizer and...
Published:
Last Updated:
One good plan for stockholders who are seeing gains evaporate is to rotate to a more defensive sector. Large cap pharmaceutical stocks totally fit the bill.
Published:
Last Updated:
24/7 Wall Street has evaluated three major Dow components in the pharmaceutical industry and presented the bullish and bearish case for each in 2016.
Published:
Last Updated:
Dogs of the Dow is a dividend strategy for investors to buy what are either "cheap" or "beaten up" Dow stocks. Unfortunately, 2015 was an awful year for the members of the Dogs of the Dow.
Published:
Last Updated:
These companies all provide drugs and medical devices that help hundreds of thousands of people daily lead a better life. They make good sense for conservative portfolios looking for income and...
Published:
Last Updated: